General
Topic | Replies | Views | Activity | |
---|---|---|---|---|
About the General category
|
![]() |
0 | 121 | 25 April 2021 |
Enrichment analysis for a list of Protein
|
![]() ![]() |
2 | 14 | 1 July 2022 |
Gene Symbol to Ensembl ID
|
![]() ![]() ![]() |
4 | 30 | 28 June 2022 |
Searching for associations with a set of diseases and phenotypes (and how to find that set)
|
![]() ![]() |
1 | 80 | 10 June 2022 |
How to get ontology data for Open Targets Genetics?
|
![]() ![]() |
1 | 21 | 10 June 2022 |
How to group associations by therapeutic area?
|
![]() ![]() ![]() ![]() ![]() |
8 | 77 | 6 June 2022 |
Overall V2G score calculation?
|
![]() ![]() |
3 | 84 | 12 May 2022 |
PheWAS significance threshold
|
![]() ![]() |
2 | 89 | 25 April 2022 |
What is ebisearchEvidence/Association?
|
![]() ![]() |
1 | 68 | 14 December 2021 |
Comparable association scores?
|
![]() ![]() ![]() |
6 | 229 | 28 July 2021 |
How to interpret colocalisation analyses, lead and tag variants in the Open Targets Genetics Portal
|
![]() |
0 | 113 | 17 June 2021 |
Misleading maximum clinical trial phase?
|
![]() ![]() |
2 | 130 | 11 May 2021 |
Welcome message
|
![]() |
2 | 128 | 29 April 2021 |